Your browser doesn't support javascript.
loading
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.
Zhang, Yong; Liu, Dan; Zhang, Zhouao; Huang, Xiaoyu; Cao, Jiang; Wang, Gang; Du, Xue; Wang, Zhouyi; Yang, Mingjin; Luo, Tiancheng; Liu, Sha; Zhang, Wan; Sheng, Ying; Li, Huizhong; Zhang, Wei; Chen, Hao; Zhang, Shenyang; Wang, Xiaopeng; Meng, Wenqing; Zong, Shenghua; Shi, Ming; Zheng, Junnian; Cui, Guiyun.
Afiliación
  • Zhang Y; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Liu D; Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Zhang Z; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Huang X; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Cao J; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Wang G; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Du X; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Wang Z; Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Yang M; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Luo T; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Liu S; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Zhang W; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Sheng Y; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Li H; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Zhang W; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Chen H; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Zhang S; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Wang X; Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Meng W; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Zong S; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Shi M; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Zheng J; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
  • Cui G; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
J Neurol ; 271(7): 4655-4659, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38602546

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Colinérgicos / Antígenos CD19 / Miastenia Gravis Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Colinérgicos / Antígenos CD19 / Miastenia Gravis Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2024 Tipo del documento: Article País de afiliación: China